TYOBF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Revenue ScaleRevenue has expanded materially across the reported period, indicating broader sales scale for Toyobo’s materials portfolio. Sustained revenue near ¥422B in 2025–2026 provides a larger operating base, although growth alone does not ensure margins.
2026 Earnings ReboundThe 2026 rebound shows that earnings can recover materially when operating conditions improve, supporting internal funding capacity and resilience. However, durability remains unproven because the pack also records thin profits in 2024–2025.
Operating Cash Flow ImprovementOperating cash flow rose substantially from 2023 to 2026, improving the company’s capacity to fund operations, investment, and debt service. This represents a stronger financial foundation than earlier years, despite the broader record of uneven cash conversion.
Bears Say
Profitability VolatilityLarge swings from loss to thin profits and then a sharp rebound indicate sensitivity to costs, pricing, and industry cycles. This makes earnings quality less predictable and reduces confidence that stronger 2026 profitability will persist.
Elevated LeverageDebt materially above equity limits financial flexibility and can increase refinancing and interest burdens during weaker operating periods. Although equity reached about ¥213B in 2026, leverage remains a structural constraint on resilience.
Uneven Free Cash FlowSeveral consecutive years of negative free cash flow suggest that investment needs or working-capital swings have outpaced internally generated cash. The 2026 recovery is encouraging, but the history indicates potential reliance on financing flexibility.
Toyobo Co News
TYOBF FAQ
What was Toyobo Co Ltd’s price range in the past 12 months?
Currently, no data Available
What is Toyobo Co Ltd’s market cap?
Toyobo Co Ltd’s market cap is $948.97M.
When is Toyobo Co Ltd’s upcoming earnings report date?
Toyobo Co Ltd’s upcoming earnings report date is Nov 05, 2026 which is in 58 days.
How were Toyobo Co Ltd’s earnings last quarter?
Toyobo Co Ltd released its earnings results on Aug 06, 2026. The company reported $0.22 earnings per share for the quarter.
Is Toyobo Co Ltd overvalued?
According to Wall Street analysts Toyobo Co Ltd’s price is currently Undervalued.
Does Toyobo Co Ltd pay dividends?
Toyobo Co Ltd does not currently pay dividends.
What is Toyobo Co Ltd’s EPS estimate?
Toyobo Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Toyobo Co Ltd have?
Currently, no data Available
What happened to Toyobo Co Ltd’s price movement after its last earnings report?
Toyobo Co Ltd reported an EPS of $0.22 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Toyobo Co Ltd?
Currently, no hedge funds are holding shares in TYOBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Toyobo Co Ltd
Established in 1882 and headquartered in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise delivering a diverse range of products. The company specializes in the manufacturing of films and advanced polymers, industrial components, healthcare solutions, and various textile goods. Its films and functional polymers division produces industrial PET films for applications such as liquid crystal displays and optics, in addition to synthetic papers. It also supplies a variety of packaging films, including PET, polyolefin, and nylon options for food products, along with heat-shrink PET films. The company's portfolio of functional polymers features engineering plastics, industrial adhesives, specialized coatings, photosensitive printing plates, acrylate polymers, and electronic materials. This segment further encompasses rubber and coat processing, as well as pharmaceutical intermediates. Within its industrial materials segment, Toyobo develops functional fibers for airbag construction, polyethylene fibers, and PBO fibers. It also creates functional filters for automotive and indoor environments, materials for anti-pollution solvent adsorption, and fiber components utilized in vehicle parts. In the healthcare sector, the company provides a comprehensive selection of bio-products, which includes enzymes for diagnostic purposes, diagnostic systems, and research reagents. Its contributions also extend to artificial kidney hollow fibers, anti-clotting substances, and seawater desalination modules. For textiles, Toyobo supplies functional fabrics suitable for sports clothing, undergarments, and uniforms, alongside synthetic filaments. The company markets apparel under its Munsingwear brand, acrylic fibers under Exlan, and acrylate fibers under the eks brand, while also engaging in general textile product commerce. Beyond these offerings, Toyobo serves as a contract manufacturer for injectable pharmaceuticals.





